Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Hematologic Malignancies
NCT00003661Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Jun 1998
- Primary completion
- Nov 1999
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of umbilical cord blood in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic myelogenous leukemia (CML) and 3 more, sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Rate of Hematologic Reconstitution and Rate of Immune Reconstitution. Started Jun 1998; status: completed.
02
Drugs
umbilical cord blood
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)chronic myelogenous leukemia (CML)myelodysplastic syndrome (MDS)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00003661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003661.